Prochlorperazine |
Presentation |
• 12.5mg in 1ml amp | ||||||||||||
Pharmacology |
• Antiemetic | ||||||||||||
Actions |
• Acts on several central neuro-transmitter systems | ||||||||||||
Metabolism |
• Metabolised by the liver and excreted by the kidneys | ||||||||||||
Primary Emergency Indications |
• Treatment or prophylaxis of nausea/vomiting Adult for: - Motion sickness - Planned aeromedical evacuation - Known allergy or contraindication to Metoclopramide administration - Headache irrespective of nausea/vomiting - Vertigo |
||||||||||||
Contraindications |
• Children • Circulatory collapse • CNS depression • Previous hypersensitivity |
||||||||||||
Precautions |
• Hypotension • Epilepsy • Pts effected by alcohol or on anti-depressants |
||||||||||||
Route of Administration |
• IM | ||||||||||||
Side Effects |
• Drowsiness • Blurred vision • Hypotension • Sinus tachycardia • Skin rash • Extrapyramidal reactions, usually the dystonic type |
||||||||||||
Special Notes |
|||||||||||||
Therapeutic Effect |
|